2023年5月30日
Generation and purification of ACTH-secreting hPSC-derived pituitary cells for effective transplantation.
Stem cell reports
- Shiori Taga
- Hidetaka Suga
- Tokushige Nakano
- Atsushi Kuwahara
- Naoko Inoshita
- Yu Kodani
- Hiroshi Nagasaki
- Yoshitaka Sato
- Yusuke Tsumura
- Mayu Sakakibara
- Mika Soen
- Tsutomu Miwata
- Hajime Ozaki
- Mayuko Kano
- Kenji Watari
- Atsushi Ikeda
- Mitsugu Yamanaka
- Yasuhiko Takahashi
- Sachiko Kitamoto
- Yohei Kawaguchi
- Takashi Miyata
- Tomoko Kobayashi
- Mariko Sugiyama
- Takeshi Onoue
- Yoshinori Yasuda
- Daisuke Hagiwara
- Shintaro Iwama
- Yoshitaka Tomigahara
- Toru Kimura
- Hiroshi Arima … 全て表示
- 巻
- 18
- 号
- 8
- 開始ページ
- 1657
- 終了ページ
- 1671
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/j.stemcr.202305002
Pituitary organoids are promising graft sources for transplantation in treatment of hypopituitarism. Building on development of self-organizing culture to generate pituitary-hypothalamic organoids (PHOs) using human pluripotent stem cells (hPSCs), we established techniques to generate PHOs using feeder-free hPSCs and to purify pituitary cells. The PHOs were uniformly and reliably generated through preconditioning of undifferentiated hPSCs and modulation of Wnt and TGF-β signaling after differentiation. Cell sorting using EpCAM, a pituitary cell-surface marker, successfully purified pituitary cells, reducing off-target cell numbers. EpCAM-expressing purified pituitary cells reaggregated to form three-dimensional pituitary spheres (3D-pituitaries). These exhibited high adrenocorticotropic hormone (ACTH) secretory capacity and responded to both positive and negative regulators. When transplanted into hypopituitary mice, the 3D-pituitaries engrafted, improved ACTH levels, and responded to in vivo stimuli. This method of generating purified pituitary tissue opens new avenues of research for pituitary regenerative medicine.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.stemcr.202305002
- PubMed ID : 37295423
- PubMed Central 記事ID : PMC10444568